Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$0.63 - $0.96 $15,813 - $24,096
-25,100 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$0.92 - $1.22 $552 - $732
-600 Reduced 2.33%
25,100 $25,000
Q3 2021

Nov 15, 2021

SELL
$0.67 - $1.51 $23,450 - $52,850
-35,000 Reduced 57.66%
25,700 $33,000
Q2 2021

Aug 13, 2021

BUY
$0.75 - $1.1 $37,125 - $54,450
49,500 Added 441.96%
60,700 $47,000
Q1 2021

May 13, 2021

BUY
$0.96 - $1.74 $10,752 - $19,488
11,200 New
11,200 $12,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $134M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.